JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2002; 40:1723-1730
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bellamy, M. F.
Right arrow Articles by Enriquez-Sarano, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bellamy, M. F.
Right arrow Articles by Enriquez-Sarano, M.

CLINICAL STUDY: AORTIC STENOSIS PROGRESSION AND CHOLESTEROL

Association of cholesterol levels, hydroxymethylglutaryl coenzyme-a reductase inhibitor treatment, and progression of aortic stenosis in the community

Michael F. Bellamy, MD, MRCP*, Patricia A. Pellikka, MD, FACC*, Kyle W. Klarich, MD, FACC*, A. Jamil Tajik, MD, FACC* and Maurice Enriquez-Sarano, MD, FACC*,*

* Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA

Manuscript received March 20, 2002; revised manuscript received August 1, 2002, accepted August 26, 2002.

* Reprint requests and correspondence: Dr. Maurice Enriquez-Sarano, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.
Sarano.Maurice{at}mayo.edu

OBJECTIVES: This study was designed to analyze the association among cholesterol levels, lipid-lowering treatment, and progression of aortic stenosis (AS) in the community.

BACKGROUND: Aortic stenosis is a progressive disease for which there is no known medical treatment to prevent or slow progression. Despite plausible pathologic mechanisms linking hypercholesterolemia to AS progression, clinical studies have been inconsistent and affected by referral bias, and the role of lipid-lowering therapy is uncertain.

METHODS: We determined the association between blood cholesterol levels and progression of native AS (assessed by Doppler echocardiography at baseline and at least six months later; mean interval, 3.7 ± 2.3 years) in a community-based study of 156 patients (age 77 ± 12 years; 90 men). Thirty-eight patients received statin treatment during follow-up.

RESULTS: In untreated subjects, mean gradient increased from 22 ± 12 mm Hg to 39 ± 19 mm Hg, and aortic valve area (AVA) decreased from 1.20 ± 0.35 cm2 to 0.91 ± 0.33 cm2 (both p < 0.001). The annualized change in AVA was –0.09 ± 0.17 cm2/year (–7% ± 13%/year). Neither total cholesterol (r = –0.01, p = 0.92) nor low-density lipoprotein cholesterol (r = 0.01; p = 0.88) showed a significant correlation to AS progression. Nevertheless, progression of AS was slower in patients receiving statins compared with untreated patients (decrease in AVA –3 ± 10% vs. –7 ± 13% per year, respectively; p = 0.04), even when adjusted for age, gender, cholesterol, and baseline valve area (p = 0.04). The association of statin treatment with slower progression was confirmed when analysis was restricted to patients coming for a systematic follow-up (p=0.02). The odds ratio of AS progression with statin treatment was 0.46 (95% confidence interval, 0.21 to 0.96).

CONCLUSIONS: In the community, progression of AS shows no trend of association with cholesterol levels. Statin treatment, however, is associated with slower progression, suggesting that the effects of statin treatment on progression of AS should be pursued with appropriate clinical trials.

Abbreviations and Acronyms
  AS
  aortic stenosis
  AVA
  aortic valve area
  CI
  confidence interval
  HDL-C
  high-density lipoprotein cholesterol
  MG
  mean gradient
  LDL-C
  low-density lipoprotein cholesterol
  TC
  total cholesterol




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
B. A. Carabello
Aortic Stenosis: It Is a Hot Topic: The Link to Coronary Artery Disease
J. Am. Coll. Cardiol., August 26, 2008; 52(9): 764 - 766.
[Full Text] [PDF]


Home page
ICVTSHome page
C. E. Tourmousoglou, S. Lalos, and T. Psarros
Do statins slow the progression of aortic valve stenosis?
Interactive CardioVascular and Thoracic Surgery, August 1, 2008; 7(4): 684 - 689.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Helske, T. Miettinen, H. Gylling, M. Mayranpaa, J. Lommi, H. Turto, K. Werkkala, M. Kupari, and P. T. Kovanen
Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves
J. Lipid Res., July 1, 2008; 49(7): 1511 - 1518.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
T. R. Pedersen
Overview of clinical trials on calcific aortic stenosis
Eur. Heart J. Suppl., July 1, 2008; 10(suppl_E): E31 - E40.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
D. S. Owens, R. Katz, E. Johnson, D. M. Shavelle, J. L. Probstfield, J. Takasu, J. R. Crouse, J. J. Carr, R. Kronmal, M. J. Budoff, et al.
Interaction of Age With Lipoproteins as Predictors of Aortic Valve Calcification in the Multi-Ethnic Study of Atherosclerosis
Arch Intern Med, June 9, 2008; 168(11): 1200 - 1207.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. S. Jassal, J. W. Tam, K. M. Bhagirath, I. Gaboury, R. A. Sochowski, J. G. Dumesnil, P. J. Giannoccaro, J. Jue, A. S. Pandey, C. D. Joyner, et al.
Association of mitral annular calcification and aortic valve morphology: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study
Eur. Heart J., June 2, 2008; 29(12): 1542 - 1547.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Pachon and J. Zamorano
Mitral annular calcifications and aortic valve stenosis
Eur. Heart J., June 2, 2008; 29(12): 1478 - 1480.
[Full Text] [PDF]


Home page
Card Surg AdultHome page
M. Enriquez-Sarano, V. T. Nkomo, and H. Michelena
Principles and Practice of Echocardiography in Cardiac Surgery
Card. Surg. Adult, January 1, 2008; 3(2008): 315 - 348.
[Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Mohty, P. Pibarot, J.-P. Despres, C. Cote, B. Arsenault, A. Cartier, P. Cosnay, C. Couture, and P. Mathieu
Association Between Plasma LDL Particle Size, Valvular Accumulation of Oxidized LDL, and Inflammation in Patients With Aortic Stenosis
Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 187 - 193.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Goldbarg, S. Elmariah, M. A. Miller, and V. Fuster
Insights Into Degenerative Aortic Valve Disease
J. Am. Coll. Cardiol., September 25, 2007; 50(13): 1205 - 1213.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Arishiro, M. Hoshiga, N. Negoro, D. Jin, S. Takai, M. Miyazaki, T. Ishihara, and T. Hanafusa
Angiotensin Receptor-1 Blocker Inhibits Atherosclerotic Changes and Endothelial Disruption of the Aortic Valve in Hypercholesterolemic Rabbits
J. Am. Coll. Cardiol., April 3, 2007; 49(13): 1482 - 1489.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Messika-Zeitoun, L. F. Bielak, P. A. Peyser, P. F. Sheedy, S. T. Turner, V. T. Nkomo, J. F. Breen, J. Maalouf, C. Scott, A. J. Tajik, et al.
Aortic Valve Calcification: Determinants and Progression in the Population
Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 642 - 648.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. P. Griffin
Statins in Aortic Stenosis: New Data From a Prospective Clinical Trial
J. Am. Coll. Cardiol., February 6, 2007; 49(5): 562 - 564.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. M. Moura, S. F. Ramos, J. L. Zamorano, I. M. Barros, L. F. Azevedo, F. Rocha-Goncalves, and N. M. Rajamannan
Rosuvastatin Affecting Aortic Valve Endothelium to Slow the Progression of Aortic Stenosis
J. Am. Coll. Cardiol., February 6, 2007; 49(5): 554 - 561.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion, G. Filippatos, F. Flachskampf, R. Hall, B. Iung, et al.
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology
Eur. Heart J., January 26, 2007; (2007) ehl428v1.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
D. Chua and K. Kalb
Statins and Progression of Calcified Aortic Stenosis
Ann. Pharmacother., December 1, 2006; 40(12): 2195 - 2199.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. C. Johnson, J. A. Leopold, and J. Loscalzo
Vascular Calcification: Pathobiological Mechanisms and Clinical Implications
Circ. Res., November 10, 2006; 99(10): 1044 - 1059.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J R Ortlepp, M Pillich, V Mevissen, C Krantz, M Kimmel, R Autschbach, G Langebartels, J Erdmann, R Hoffmann, and K Zerres
APOE alleles are not associated with calcific aortic stenosis
Heart, October 1, 2006; 92(10): 1463 - 1466.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. D. O'Brien
Pathogenesis of Calcific Aortic Valve Disease: A Disease Process Comes of Age (and a Good Deal More)
Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1721 - 1728.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Briand, I. Lemieux, J. G. Dumesnil, P. Mathieu, A. Cartier, J.-P. Despres, M. Arsenault, J. Couet, and P. Pibarot
Metabolic Syndrome Negatively Influences Disease Progression and Prognosis in Aortic Stenosis
J. Am. Coll. Cardiol., June 6, 2006; 47(11): 2229 - 2236.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D E Newby, S J Cowell, and N A Boon
Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both?
Heart, June 1, 2006; 92(6): 729 - 734.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
V. Liebe, M. Brueckmann, M. Borggrefe, and J. J. Kaden
Statin therapy of calcific aortic stenosis: hype or hope?
Eur. Heart J., April 1, 2006; 27(7): 773 - 778.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Skowasch, S Schrempf, C J Preusse, J A Likungu, A Welz, B Luderitz, and G Bauriedel
Tissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive protein concentrations and modification by statins
Heart, April 1, 2006; 92(4): 495 - 498.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. Skowasch, S. Schrempf, N. Wernert, M. Steinmetz, A. Jabs, I. Tuleta, U. Welsch, C. J. Preusse, J. A. Likungu, A. Welz, et al.
Cells of primarily extravalvular origin in degenerative aortic valves and bioprostheses
Eur. Heart J., December 1, 2005; 26(23): 2576 - 2580.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
H. Baumgartner
Aortic stenosis: medical and surgical management
Heart, November 1, 2005; 91(11): 1483 - 1488.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. Weisenberg, Y. Sahar, G. Sahar, Y. Shapira, Z. Iakobishvili, B. A. Vidne, and A. Sagie
Atherosclerosis of the aorta is common in patients with severe aortic stenosis: An intraoperative transesophageal echocardiographic study
J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 29 - 32.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. A. Pellikka, M. E. Sarano, R. A. Nishimura, J. F. Malouf, K. R. Bailey, C. G. Scott, M. E. Barnes, and A. J. Tajik
Outcome of 622 Adults With Asymptomatic, Hemodynamically Significant Aortic Stenosis During Prolonged Follow-Up
Circulation, June 21, 2005; 111(24): 3290 - 3295.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. J. Cowell, D. E. Newby, R. J. Prescott, P. Bloomfield, J. Reid, D. B. Northridge, N. A. Boon, and the Scottish Aortic Stenosis and Lipid Lowering Tr
A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis
N. Engl. J. Med., June 9, 2005; 352(23): 2389 - 2397.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. Rosenhek
Statins for Aortic Stenosis
N. Engl. J. Med., June 9, 2005; 352(23): 2441 - 2443.
[Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
D. W. Quinn Jr. and S. A. Spinler
Efficacy of statins in preventing progression of aortic stenosis
Am. J. Health Syst. Pharm., May 1, 2005; 62(9): 979 - 981.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. S. Borer
Aortic Stenosis and Statins: More Evidence of "Pleotropy"?
Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 476 - 477.
[Full Text] [PDF]


Home page
CirculationHome page
W. C. Roberts and J. M. Ko
Frequency by Decades of Unicuspid, Bicuspid, and Tricuspid Aortic Valves in Adults Having Isolated Aortic Valve Replacement for Aortic Stenosis, With or Without Associated Aortic Regurgitation
Circulation, February 22, 2005; 111(7): 920 - 925.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. Y.-M. Wang, S. S.-Y. Ho, M. Wang, E. K.-H. Liu, S. Ho, P. K.-T. Li, S.-F. Lui, and J. E. Sanderson
Cardiac Valvular Calcification as a Marker of Atherosclerosis and Arterial Calcification in End-stage Renal Disease
Arch Intern Med, February 14, 2005; 165(3): 327 - 332.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
Systolic murmur in an asymptomatic 70 year old man
Heart, January 1, 2005; 91(1): 125 - 125.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Helske, K. A. Lindstedt, M. Laine, M. Mayranpaa, K. Werkkala, J. Lommi, H. Turto, M. Kupari, and P. T. Kovanen
Induction of local angiotensin II-producing systems in stenotic aortic valves
J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1859 - 1866.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. M. Rajamannan and C. M. Otto
Targeted Therapy to Prevent Progression of Calcific Aortic Stenosis
Circulation, September 7, 2004; 110(10): 1180 - 1182.
[Full Text] [PDF]


Home page
CirculationHome page
R. Rosenhek, F. Rader, N. Loho, H. Gabriel, M. Heger, U. Klaar, M. Schemper, T. Binder, G. Maurer, and H. Baumgartner
Statins but Not Angiotensin-Converting Enzyme Inhibitors Delay Progression of Aortic Stenosis
Circulation, September 7, 2004; 110(10): 1291 - 1295.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Messika-Zeitoun, M.-C. Aubry, D. Detaint, L. F. Bielak, P. A. Peyser, P. F. Sheedy, S. T. Turner, J. F. Breen, C. Scott, A. J. Tajik, et al.
Evaluation and Clinical Implications of Aortic Valve Calcification Measured by Electron-Beam Computed Tomography
Circulation, July 20, 2004; 110(3): 356 - 362.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. H. O'Keefe Jr, L. Cordain, W. H. Harris, R. M. Moe, and R. Vogel
Optimal low-density lipoprotein is 50 to 70 mg/dl: Lower is better and physiologically normal
J. Am. Coll. Cardiol., June 2, 2004; 43(11): 2142 - 2146.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. M. Otto
Why is aortic sclerosis associated with adverse clinical outcomes?
J. Am. Coll. Cardiol., January 21, 2004; 43(2): 176 - 178.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. E. David and J. Ivanov
Is degenerative calcification of the native aortic valve similar to calcification of bioprosthetic heart valves?
J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 939 - 941.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. S. Farivar and L. H. Cohn
Hypercholesterolemia is a risk factor for bioprosthetic valve calcification and explantation
J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 969 - 975.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G J Morgan-Hughes, P E Owens, C A Roobottom, and A J Marshall
Three dimensional volume quantification of aortic valve calcification using multislice computed tomography
Heart, October 1, 2003; 89(10): 1191 - 1194.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
G. E. Pate, M. N. Tahir, R. T. Murphy, and J. B. Foley
Anti-inflammatory Effects of Statins in Patients with Aortic Stenosis
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2003; 8(3): 201 - 206.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
K.-L. Chan
Is aortic stenosis a preventable disease?
J. Am. Coll. Cardiol., August 20, 2003; 42(4): 593 - 599.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. M. Bashore and T. J. Gardner
Valvular heart disease
J. Am. Coll. Cardiol., July 16, 2003; 42(2): 388 - 390.
[Full Text] [PDF]


Home page
HeartHome page
N. M Rajamannan, B. Gersh, and R. O Bonow
CALCIFIC AORTIC STENOSIS: FROM BENCH TO THE BEDSIDE--EMERGING CLINICAL AND CELLULAR CONCEPTS
Heart, July 1, 2003; 89(7): 801 - 805.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. S. Pearlman
Medical treatment ofaortic stenosis: Promising, or wishful thinking?
J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1731 - 1734.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2002 by the American College of Cardiology Foundation.